Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S47445 in Alzheimer's Disease With Depressive Symptoms
NCT02626572Phase 2Completed
- Sponsor
- Servier
- Start
- Feb 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 2, randomised, double-blind trial of tulrampator in Alzheimer's disease (AD), sponsored by Servier. Started Feb 2015; status: completed.
02
Drugs
tulrampator
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02626572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02626572.